G1 cyclins and control of the cell division cycle in normal and transformed cells

Cancer Investigation

Volumn 15, Issue 2, 1997, Pages 143-152

  Hamel, Paul A ^a   Hanley Hyde, Joan ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN G1; CYCLINE; UNCLASSIFIED DRUG;

CELL CYCLE; CELL TRANSFORMATION; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL CYCLE G1 PHASE; CELL DIVISION; HUMAN; PHYSIOLOGY;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLINS; G1 PHASE; HUMANS;

EID: 0030611276     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709115767     Document Type: Review

References (96)

1. Nurse P: Universal control mechanism regulating onset of Mphase. Nature 344:503-508, 1990.
2. Reed SI: The role of the p34 kinases in the G1 to S-phase transition. Annu Rev Cell Biol 8:529-561, 1992.
3. Xiong Y, Connolly T, Futcher B, Beach D: Human D-type cyclin. Cell 65:691-699, 1991.
4. 1 cyclin (Cln) function in yeast. Cell 66:1197-1206, 1991.
5. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC: Characterization of a candidate bcl-1 gene. Mol Cell Biol. 11:4846-4853, 1991.
6. Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encolded by a bcll-linked candidate oncogene. Nature 350:512-515, 1991.
7. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A BCL-1 linked candidate oncogene which is rearranged in parathyroid tumors encodes a novel cyclin. Nature (Lond) 350:512-518, 1991.
8. 1 phase of the cell cycle. Cell 65:701-713, 1991.
9. Xiong Y, Menninger J, Beach D, Ward DC: Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13:575-584, 1992.
10. Molokura T, Keyomarsi K, Kronenberg HM, Arnold A: Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chern 267:20412-20415, 1992.
11. Aguzzi A, Kiess M, Rüedi D, Hamel PA: The different D-type cyclins are expressed in distinct tissues during mouse embryogenesis. Transgenics 2:29-39, 1996.
12. 1 phase in primary human T lyrnphocytes. J Biol Chem 268:4113-4119,1993.
13. Kiyokawa H, Busquets X, Powell CT, Ngo L, Rifkind RA, Marks PA: Cloning of a D-type cyclin from murine erythroleukemia cells. Proc Nail Acad Sci USA 89:2444-2447, 1992.
14. Won KA, Xiong Y, Beach D, Oilman MZ: Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA 89:9910-9914, 1992.
15. Cocks BG, Vairo G, Bodrug SE, Hamilton JA: Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem 267:12307-12309, 1992.
16. Kiess M, Gill RM, Hamel PA: Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10:159-166, 1995.
17. Loyer P, Glaise D, Cariou S, Baffet G, MeijerL, Guguen-Guillouzo C: Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem 269:2491-2500, 1994.
18. 1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-Cdk2 and cyclin-Cdk2 complexes. Proc Natl Acad Sci USA 90:11034-11038, 1993.
19. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJZ: Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduclion to the cell cycle. Oncogene 9:3635-3645, 1994.
20. Phillipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M: Repression of cyclin D1: A novel activity of MYC. Mol Cell Biol 14:4032-4043, 1994.
21. Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G: Absence of cyclin D/cdk complexes in cells lacking functional retionblastoma protein. Oncogene 9:1633-1640, 1994.
22. Müller H, Lucas J, Schneider A, Warthoe P, Bartek J, Eilers M, Straus M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949, 1994.
23. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 15:2600-2611, 1995.
24. Hamel PA, Gill RM, Phillips RA, Gallie BL: Transcriptional repression of the E2-containing promoters EIIaE, c-myc and RB1 by the product of the RB1 gene. Mol Cell Biol 12:3431-3438, 1992.
25. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR: The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-85, 1992.
26. Hiebert SW, Lipp M, Nevins JR: E1 A-dependem trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 86:3594-8, 1989.
27. 1 cyclins. Cell 71:323-334, 1992.
28. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV: Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13:7358-7363, 1993.
29. Labbe JC, Picard A, Peaucellier G, Cavadore JC, Nurse P, Doree M: Purification of MPF from starfish: Identification as the H1 hislone kinase p34cdc2 and a possible mechanism for its periodic activation. Cell 57:253-263, 1989.
30. cdc2 homologues. Biochem Biophys Acta 989:85-95, 1989.
31. Tsai L-H, Harlow E, Meyerson M: Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus El A-associated p33 kinase. Nature 353:174-177, 1991.
32. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514, 1992.
33. Meyerson M, Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077-2086, 1994.
34. Lew J, Huang Q-Q, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH: A brain-specific activator of cyclin-dependent kinase 5. Nature 371:423-426, 1994.
35. Tsai L-H, Delalle I, Caviness VS, Chae T, Harlow E: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423, 1994.
36. M015. EMBO J 12:3133-3142, 1993.
37. cdc2. EMBO J 12:3123-3132, 1993.
38. Fesquet D, Labbé J-C, Galas S, GirardF, Lorca T, Shuttleworth J, Dorée M, Cavadore J-C: The M015 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J 12:3111-3121, 1993.
39. Wu L, Yee A, Liu L, Carbonaro-Hall D, Venkatesan N, Tolo VT, Hall FL: Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activaling kinase. Oncogene 9:2089-2096, 1994.
40. van den Heuvel S, Harlow E: Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054, 1993.
41. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704, 1993.
42. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993.
43. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993.
44. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750-1758, 1994.
45. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578, 1994.
46. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor βand contact inhibition to cell cycle arrest. Genes Dev 8:9-22, 1994.
47. Kipl, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78:59-66, 1994.
48. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994.
49. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI: A cell cycle regulated inhibitor of cyclin dependent kinases. Proc Natl Acad Sci USA 91:5291-5295, 1994.
50. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662, 1995.
51. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649, 1995.
52. Serrano M, Hannon G, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707, 1993.
53. Ink4b is a potential effector of cell cycle arrest mediated by TGFβ, Nature 371:257-261, 1994.
54. ink4-related cdk6 inhibitor, correlates with wild type pRb function. Genes Dev 8:2939-2952, 1994.
55. Hirai H, Rouseel MF, Kato J-Y, Ashmun RA, Sherr CJ: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclein D-dependent kinases, cdk4 and cdk6. Mol Cell Biol 15:2672-2681, 1995.
56. ink4. Mol Cell Biol 15:2682-2688, 1995.
57. 1 cyclin-dependem kinases. Genes Dev 9:1149-1163, 1995.
58. Gyuris J, Golemis E, Chertkov H, Brent R: Cdi 1, a human G1 and S phase protein phosphatase that associates with cdk2. Cell 75:791-803, 1993.
59. Hannon GJ, Casso D, Beach D: KAP: A dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc Natl Acad Sci USA 91:1731-1735, 1994.
60. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679, 1994.
61. 1 progression through telracycline-regulated expression of human cyclin E. Oncogene 9:995-997, 1994.
62. Jiang W, Kahn SM, Zhou P, Zhang Y-J, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457, 1993.
63. 1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci USA 90:11513-11517, 1993.
64. 1. Genes Dev 7:812-821, 1993.
65. Koff A, Ohtsuki M, Polyak K, Roberts J, Massagué J: Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependem kinase by TGF-b. Science 260:536-539, 1993.
66. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM: TGBβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020, 1993.
67. 1 cell-cycle arrest. Genes Dev 9:204-207, 1995.
68. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma functions by ectopic expression of human cyclins. Cell 70:993-1006, 1992.
69. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRB) and pRB phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342, 1993.
70. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kalo J, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497, 1993.
71. Wang C, Petryniak B, Thompson CB, Kaelin WG, Leiden JM: Regulation of the Ets-related transcription factor E1f-1 by binding the retinoblastoma protein. Science 260:1330-1335, 1993.
72. cdk2 is a component of the E2F-cyclin A complex. Cell 68:167-176, 1992.
73. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG Jr, Livingston DM: Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172, 1994.
74. Hannon GJ, Demetrick D, Beach D: Isolation of the Rb-related p130 through its interaction with cdk2 and cyclins. Genes Dev 7:2378-2391, 1993.
75. Li Y, Graham C, Lacy S, Duncan AMV, Whyte P: The adenovirus Ela-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377, 1993.
76. Ewen ME, Xing YG, Lawrence JB, Livingston DM: Molecular cloning, chromosomal mapping, and expression of the cDNA for p 107, aretinoblastoma gene product-related protein. Cell 66:1155-1164, 1991.
77. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511, 1993.
78. Dyson N, Howley PM, Münger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 242:934-937, 1989.
79. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E: Association between anoncogene and an anti-oncogene: The adenovirus E1A proteins binds to the retinoblastoma gene product. Nature 334:124-129, 1988.
80. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM,Lee WH, Marsilio E, Paucha E, Livingston DM: SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-83, 1988.
81. Lees E, Faha B, Dulic V, Reed SI, Harlow E: Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p 107 and E2F in a temporally distinct manner. Genes Dev 6:1874-1885, 1992.
82. Ewen ME, Faha B, Harlow E, Livingston DM: Interaction of p107 with cyclin A independent of complex formation with viral oncopoteins. Science 255:85-87, 1992.
83. Faha B, Ewen ME, Tsai L-H, Livingston DM, Harlow E: Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255:87-90, 1992.
84. Hunter T, Pines J: Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 4:573-582, 1994.
85. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A: PRAD 1, a candidate BCL-1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 87:9638-9642, 1991.
86. Seto M, Yamamolo K, lida S, Akao Y, Utsumi KR, Kuonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M, Motokura T, Arnold A, Takahashi T, Ueba R: Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7:1401-1406, 1992.
87. Bodrug S, Warner B, Bath M, Lindeman G, Harris A, Adams J: Cyclin D1 Iransgene impedes lymphocyte maturation and collaborates with the myc gene. EMBO J 13:2124-2130, 1994.
88. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709-713, 1994.
89. Jung JU, Stäger M, Desrosiers RC: Virus-encoded cyclin. Mol Cell Biol 14:7235-7244, 1994.
90. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT: Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13:565-574, 1992.
91. Leach FS, Elledge SJ, Sherr CJ, Wilson JK, Markowitz S, Kinzer KW, Vogelstein B: Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53:1986-1989, 1993.
92. Hanna Z, Jankowski M, Tremblay P, Jiang X, Milatovitch A, Francke U, Jolicoeur P: The vin-1 gene, identified by provirus insertional mutatgenesis, is the cyclin D2. Oncogene 8:1661-1666, 1993.
93. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385, 1994.
94. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90:1112-1116, 1993.
95. Buckley MF, Sweeny KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133, 1993.
96. 1-phase progression in rodent fibroblasts. Genes Dev 7:1559-1571, 1993.